Nick Andrews

Insights revealed into rheumatologist-patient discussions about biologics

Publish date: February 4, 2018

An ethnographic, observational study analyzes discussions between rheumatologists and patients about starting biologics.

Publish date: January 31, 2018

Tisagenlecleucel had transitory but high-grade toxicity in this population of children and young adults.

Publish date: January 21, 2018

Immunotherapy with less chemotherapy appears effective for a neglected ALL patient subgroup: those aged 60 years and older.

Publish date: January 17, 2018

Hyperthermic intraperitoneal chemotherapy showed survival benefit without increasing risk for side effects in phase 3 study.